Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03744936 · ClinicalTrials.gov registry record
Decision Aids for Patients With Nonvalvular Chronic Atrial Fibrillation (DA4AFib)
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 34
- Enrollment target
NCT03744936: Completed study, sponsored by Mayo Clinic.
NCT03744936 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 34 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03744936 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 34 participants
- Enrollment target
Study Summary
The researchers are observing subject and clinician interaction in order to develop future education materials that will help patients and clinicians discuss atrial fibrillation and options to treat it.
Primary Outcome
The number of subjects to complete the interview process
Interventions
- OTHER Feedback
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2018-10-04 |
| Est. Completion | 2020-02-06 |
What the finished NCT03744936 record still lists
NCT03744936 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 34 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Feedback is the first listed.
NCT03744936 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03744936 about?
NCT03744936 is a clinical study titled "Decision Aids for Patients With Nonvalvular Chronic Atrial Fibrillation (DA4AFib)". The researchers are observing subject and clinician interaction in order to develop future education materials that will help patients and clinicians discuss atrial fibrillation and options to treat it.
What is the current status of trial NCT03744936?
This trial is currently completed. The enrollment target is 34 participants. The study started on 2018-10-04. Estimated completion is 2020-02-06.
What interventions are being tested in trial NCT03744936?
The interventions under investigation include: Feedback (OTHER).
Who is sponsoring clinical trial NCT03744936?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02897063 · 34 participants · Phase 1
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
- NCT03906617 · 34 participants · Phase 4
Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine
- NCT03992378 · 34 participants · NA
Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis
- NCT04047849 · 34 participants · Phase 4
Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI